Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Camarda

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
EMBO Reports|February 22, 2017
MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancerBrittany Anderton, Roman Camarda, Sanjeev Balakrishnan, et al.
Breast Cancer Research : BCR|August 2, 2020
A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte populationTaekyu Kang, Christina Yau, Christopher K Wong, et al.
Nature Chemical Biology|June 27, 2018
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancerHayley J Donnella, James T Webber, Rebecca S Levin, et al.
Cell Reports|March 12, 2020
MYC Dysregulates Mitosis, Revealing Cancer VulnerabilitiesJulia Rohrberg, Daniel Van de Mark, Meelad Amouzgar, et al.
Communications Medicine|February 20, 2024
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse modelsLauren R Begg, Adrienne M Orriols, Markella Zannikou, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibitionLauren R Begg, Adrienne M Orriols, Markella Zannikou, et al.
Nature Medicine|November 8, 2016
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expressionDai Horiuchi, Roman Camarda, Alicia Y Zhou, et al.
Nature Communications|August 20, 2025
Tumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesisJeremy Williams, Roman Camarda, Serghei Malkov, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
EMBO Reports|February 22, 2017
MYC-driven inhibition of the glutamate-cysteine ligase promotes glutathione depletion in liver cancerBrittany Anderton, Roman Camarda, Sanjeev Balakrishnan, et al.
Breast Cancer Research : BCR|August 2, 2020
A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte populationTaekyu Kang, Christina Yau, Christopher K Wong, et al.
Nature Chemical Biology|June 27, 2018
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancerHayley J Donnella, James T Webber, Rebecca S Levin, et al.
Cell Reports|March 12, 2020
MYC Dysregulates Mitosis, Revealing Cancer VulnerabilitiesJulia Rohrberg, Daniel Van de Mark, Meelad Amouzgar, et al.
Communications Medicine|February 20, 2024
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse modelsLauren R Begg, Adrienne M Orriols, Markella Zannikou, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibitionLauren R Begg, Adrienne M Orriols, Markella Zannikou, et al.
Nature Medicine|November 8, 2016
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expressionDai Horiuchi, Roman Camarda, Alicia Y Zhou, et al.
Nature Communications|August 20, 2025
Tumor cell-adipocyte gap junctions activate lipolysis and contribute to breast tumorigenesisJeremy Williams, Roman Camarda, Serghei Malkov, et al.
Pageof 2